Today: 2 February 2026
Subscribe
Browse Category

Earnings Reports News 16 December 2025

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s, Inc. (NYSE: DDS) is having one of those “only-in-markets” weeks: the stock recently tagged fresh highs, investors chased a $30 special dividend, and now the share price is digesting both the rally and the dividend mechanics. As of Tuesday, Dec. 16, 2025, DDS was trading around $645.61, down roughly 4.9% on the day, after opening near $678 and swinging…
16 December 2025
····
Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Accenture plc (NYSE: ACN) enters mid-December with two stock-moving narratives colliding at once: a fresh Wall Street vote of confidence and another targeted step deeper into the AI infrastructure buildout. On Tuesday, December 16, 2025, Morgan Stanley upgraded Accenture to Overweight and lifted its price target to $320, citing a “valuation floor” and early signs of demand stabilization and recovery.…
16 December 2025
·····
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

December 16, 2025 — ABIVAX Société Anonyme (listed as ABVX on Euronext Paris and Nasdaq) is back in the spotlight today after publishing third-quarter 2025 financial results and reiterating a long cash runway—news that didn’t stop the stock from pulling back as investors digested widening losses and the sheer scale of the rally already priced in. In U.S. trading, Abivax’s…
16 December 2025
·····
Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan, Inc. (NASDAQ: NAVN) stock was one of the market’s sharpest decliners on Tuesday, December 16, 2025, sliding roughly high-teens after the company’s first post-IPO earnings report landed with a thud—and after investors digested news that the company’s CFO plans to step down early next month. Barron’s The selloff is a classic public-market paradox: the operating business is still growing…
16 December 2025
····
Pfizer Stock (PFE) Slides After 2026 Guidance: COVID Sales Drop, Patent Cliff and Analyst Forecasts in Focus

Pfizer Stock (PFE) Slides After 2026 Guidance: COVID Sales Drop, Patent Cliff and Analyst Forecasts in Focus

Pfizer Inc. (NYSE: PFE) shares fell sharply in U.S. trading on Tuesday, December 16, 2025, as investors weighed the drugmaker’s first look at full-year 2026 guidance, an updated 2025 revenue outlook, and fresh commentary on cost savings and capital allocation. By late morning ET, Pfizer stock was trading around $25, down roughly 5% on the day after swinging between the…
16 December 2025
·····
Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope, Inc. (NASDAQ: NTSK) stock is back in motion on December 16, 2025, rebounding after a sharp post-earnings slide that reminded investors of a simple truth about newly public, high-growth cybersecurity names: the fundamentals can be strong and the stock can still whip around like a drone in a wind tunnel. By late morning in U.S. trading, Netskope shares were…
16 December 2025
·····
Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

December 16, 2025 — Johnson & Johnson stock (NYSE: JNJ) is trading lower on Tuesday after pushing to fresh highs earlier this week, as investors weigh a mix of pipeline momentum, legal headlines, and an approaching earnings update that could clarify the company’s 2026 trajectory. StockAnalysis Below is what’s moving Johnson & Johnson shares right now, what Wall Street is…
16 December 2025
·····
Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Corporation (NYSE: BAC) is trading near a multi‑year peak on Tuesday, December 16, 2025, with investors weighing (1) a fresh round of U.S. labor-market data that’s reshaping expectations for the Federal Reserve’s next move, (2) new regulatory and consumer-banking fee headlines, and (3) the countdown to Bank of America’s fourth‑quarter 2025 earnings report on January 14, 2026.…
16 December 2025
·····
GE Aerospace Stock (GE) Today: Citi’s $386 Target, FAA LEAP Directive, Dividend Date, and What to Watch Ahead of Q4 Earnings

GE Aerospace Stock (GE) Today: Citi’s $386 Target, FAA LEAP Directive, Dividend Date, and What to Watch Ahead of Q4 Earnings

December 16, 2025 — GE Aerospace stock (NYSE: GE) traded around $299 in late morning U.S. hours Tuesday, modestly lower on the day, as investors digested a mix of fresh Wall Street coverage, a regulatory update tied to CFM’s LEAP engine family, and a steady drumbeat of defense and manufacturing headlines. StockAnalysis After a powerful 2025 run, the near-term question…
16 December 2025
·····
Stock Market Today: Dow and S&P 500 Turn Choppy on Delayed Jobs Data; Lennar Earnings in Focus After the Bell (Dec. 16, 2025)

Stock Market Today: Dow and S&P 500 Turn Choppy on Delayed Jobs Data; Lennar Earnings in Focus After the Bell (Dec. 16, 2025)

U.S. stocks were trading in a tight, volatile range late Tuesday morning as Wall Street digested a rare burst of catch-upeconomic data after the recent government shutdown—while investors also looked ahead to a small but potentially market-moving after-hours earnings slate led by homebuilder Lennar.  Reuters By late morning in New York, the Dow Jones Industrial Average, S&P 500, and Nasdaq were hovering near flat after an…
16 December 2025
····
Snowflake vs Alphabet: Google Cloud Backlog Hits $155B as Citi Keeps Buy on SNOW on December 16, 2025

Snowflake vs Alphabet: Google Cloud Backlog Hits $155B as Citi Keeps Buy on SNOW on December 16, 2025

As the AI boom turns data into the new battleground, investors are once again weighing a classic cloud-data dilemma: buy the focused pure-play (Snowflake) or back the diversified giant (Alphabet) with Google Cloud’s BigQuery. That debate intensified heading into December 16, 2025, after fresh analyst commentary compared Snowflake (SNOW) and Alphabet (GOOGL) side by side, and as Wall Street continued…
16 December 2025
·····
B. Riley Financial (RILY) Stock: Overdue Q2 Filing, Profit Swing, Debt Cut, and Nasdaq Deadlines in Focus on Dec. 16, 2025

B. Riley Financial (RILY) Stock: Overdue Q2 Filing, Profit Swing, Debt Cut, and Nasdaq Deadlines in Focus on Dec. 16, 2025

B. Riley Financial, Inc. (NASDAQ: RILY) is back in the spotlight on December 16, 2025, after the company filed its overdue second-quarter 2025 Form 10‑Q and reported results that showed a sharp swing back to profitability—alongside a sizable reduction in total debt. The update matters for more than just the quarter’s headline numbers: it’s also directly tied to the company’s…
16 December 2025
····
1 … 194 195 196 197 198 … 301

Stock Market Today

  • William Blair Upgrades Palantir to Outperform Ahead of Earnings, Targets $200
    February 2, 2026, 9:45 AM EST. William Blair upgraded Palantir to an outperform rating from market perform before its Tuesday earnings report. Analyst Louie DiPalma set a $200 price target, suggesting a 36% upside from current levels. Shares dropped 29% from November highs but are 78% up year-on-year. DiPalma cited strong momentum and Palantir's leadership in the AI supply chain despite broader software sector selloffs. He highlighted robust government and commercial contract growth, expecting a "very strong" fourth quarter and operating margin expansion to 65% within five years. Free cash flow could reach $7 billion by 2030, supported by sustained revenue growth. The analyst warned of potential post-earnings volatility but sees shares rebounding above $200 within 12 months.
Go toTop